As of 2024-12-14, the Relative Valuation of Neuropace Inc (NPCE) is (36.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.91 USD, the upside of Neuropace Inc based on Relative Valuation is -433.2%.
The range of the Relative Valuation is (36.78) - (36.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 39.1x - 42.2x | 40.6x |
| Forward P/E multiples | 34.1x - 38.9x | 36.7x |
| Fair Price | (36.78) - (36.65) | (36.35) |
| Upside | -437.1% - -435.9% | -433.2% |
| Date | P/E |
| 2024-12-12 | -11.59 |
| 2024-12-11 | -11.77 |
| 2024-12-10 | -12.23 |
| 2024-12-09 | -11.64 |
| 2024-12-06 | -11.99 |
| 2024-12-05 | -11.99 |
| 2024-12-04 | -11.89 |
| 2024-12-03 | -12.68 |
| 2024-12-02 | -12.00 |
| 2024-11-29 | -11.26 |
| 2024-11-27 | -10.89 |
| 2024-11-26 | -10.84 |
| 2024-11-25 | -11.33 |
| 2024-11-22 | -10.31 |
| 2024-11-21 | -9.56 |
| 2024-11-20 | -9.77 |
| 2024-11-19 | -9.75 |
| 2024-11-18 | -9.51 |
| 2024-11-15 | -9.54 |
| 2024-11-14 | -10.29 |
| 2024-11-13 | -9.72 |
| 2024-11-12 | -7.59 |
| 2024-11-11 | -7.74 |
| 2024-11-08 | -7.98 |
| 2024-11-07 | -8.03 |
| 2024-11-06 | -8.29 |
| 2024-11-05 | -7.43 |
| 2024-11-04 | -6.77 |
| 2024-11-01 | -6.68 |
| 2024-10-31 | -6.85 |
| 2024-10-30 | -7.36 |
| 2024-10-29 | -6.90 |
| 2024-10-28 | -6.78 |
| 2024-10-25 | -6.75 |
| 2024-10-24 | -6.42 |
| 2024-10-23 | -6.27 |
| 2024-10-22 | -6.38 |
| 2024-10-21 | -6.59 |
| 2024-10-18 | -6.88 |
| 2024-10-17 | -6.79 |
| 2024-10-16 | -6.84 |
| 2024-10-15 | -6.86 |
| 2024-10-14 | -6.86 |
| 2024-10-11 | -7.02 |
| 2024-10-10 | -6.60 |
| 2024-10-09 | -6.49 |
| 2024-10-08 | -6.82 |
| 2024-10-07 | -7.10 |
| 2024-10-04 | -7.26 |
| 2024-10-03 | -7.39 |